Hepatitis C and B-cell lymphoma
Authors:
- G. DusheikoGDG. Dusheiko
- A. JonesAJA. Jones
Open Access
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 14 (9) , 1341-1345
Abstract
The association between the hepatitis C virus and B-cell non-Hodgkin’s lymphomas is controversial. We review the epidemiological evidence behind the association, and look at the reasons behind the variation in study findings. There is increasing evidence of the pathogenesis of hepatitis C-associated lymphoma. Treatment of the hepatitis C virus with antiviral therapy may lead to the regression of some low-grade lymphomas. The management of other hepatitis C-associated lymphomas is similar to that of conventional lymphoma, although viral reactivation and subsequent immune reconstitution hepatitis can complicate chemotherapy.Keywords
This publication has 48 references indexed in Scilit:
- Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignanciesCancer, 1998
- Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytomaAnnals of Oncology, 1998
- Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern ItalyHepatology, 1997
- Hepatitis C virus and non‐Hodgkin's lymphomasBritish Journal of Haematology, 1996
- Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virusThe Lancet, 1996
- Prevalence of chronic liver disease in the general population of northern Italy: The dionysos studyHepatology, 1994
- Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemiaBlood, 1994
- Hepatitis C virus infection in patients with non‐Hodgkin's lymphomaBritish Journal of Haematology, 1994
- A Role for Hepatitis C Virus Infection in Type II CryoglobulinemiaNew England Journal of Medicine, 1992
- Essential Mixed Cryoglobulinemia, Type II: A Manifestation of a Low-Grade Malignant Lymphoma?Acta Haematologica, 1988